CraigLTendlerMD

PubMed

• 33 citations
  Predictors of response to anti-IL6 monoclonal antibody therapy (siltuximab) in idiopathic multicentric Castleman disease: secondary analyses of phase II clinical trial...
  Deanna E Morra, Sheila K Pierson, Dustin Shilling, Sepideh Nemat, Carlos Appiani, Mary Guilfoyle, Craig Tendler, Frits van Rhee, David C. Fajgenbaum> ;British Journal of Haematology. 2019 Jan 1
• 70 citations
  Lenalidomide, bortezomib, pegylated liposomal doxorubicin, and dexamethasone in newly diagnosed multiple myeloma: a phase 1/2 Multiple Myeloma Research Consortium trial
  Andrzej Jakubowiak, Kent A. Griffith, Donna E. Reece, Craig C. Hofmeister, S. Lonial, Todd M. Zimmerman, Erica L. Campagnaro, Robert L. Schlossman, Jacob P. Laubach, N...> ;Blood. 2011 Jul 21
• 88 citations
  Pegylated Interferon Alfa-2b Treatment for Patients With Solid Tumors: A Phase I/II Study
  Ronald M. Bukowski, Marc S. Ernstoff, Martin Gore, John Nemunaitis, Robert Amato, Samir K. Gupta, Craig L. Tendler> ;Journal of Clinical Oncology. 2002 Sep 15
• 42 citations
  Abnormal cytokine expression in Sézary and adult T-cell leukemia cells correlates with the functional diversity between these T-cell malignancies.
  C L Tendler, Jack D. Burton, J Jaffe, David Danielpour, M Charley, J P McCoy, Mark R. Pittelkow, Thomas A. Waldmann> ;Cancer Research. 1994 Aug 15
• Local control measures in a toddler with a pelvic primitive neuroectodermal tumor
  Craig L. Tendler, Lynda R Mandell, Linda Granowetter> ;Medical and Pediatric Oncology. 1993 Jan 1
• 96 citations
  Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis.
  Craig L. Tendler, Steven J. Greenberg, Jack D. Burton, David Danielpour, Seong-Jin Kim, William A. Blattner, Angela Manns, Thomas A. Waldmann> ;Journal of Cellular Biochemistry. 1991 Aug 1
• 5 citations
  Lymphokine receptor-directed therapy: a model of immune intervention.
  Thomas A. Waldmann, Angus Grant, Craig L. Tendler, Steven J. Greenberg, Carolyn K. Goldman, Richard N. Bamford, Richard P. Junghans, David E. Nelson> ;Journal of Clinical Immunology. 1990 Nov 1
• 175 citations
  Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications an...
  Craig L. Tendler, Steven J. Greenberg, Blattner Wa, Angela Manns, E Murphy, Thomas A. Fleisher, Barrie Hanchard, Owen St. C. Morgan, Jack D. Burton, David L. Nelson> ;Proceedings of the National Academy of Sciences of the United States of America. 1990 Jul 1
• 193 citations
  Transactivation of the transforming growth factor beta 1 (TGF-beta 1) gene by human T lymphotropic virus type 1 tax: a potential mechanism for the increased production...
  Seong-Jin Kim, John H. Kehrl, Jack D. Burton, Craig L. Tendler, Kuan-Teh Jeang, David Danielpour, C. Thevenin, Kyung Young Kim, Michael B. Sporn, Anita B. Roberts> ;The Journal of Experimental Medicine. 1990 Jul 1
• Medication dosages during pediatric emergencies: a simple and comprehensive guide.
  Craig L. Tendler, Susan Grossman, Judith Tenenbaum> ;Pediatrics. 1989 Oct 1
• Join now to see all

Journal Articles

• Predictors of Response to Anti‐IL6 Monoclonal Antibody Therapy (Siltuximab) in Idiopathic Multicentric Castleman Disease: Secondary Analyses of Phase II Clinical Trial...  
  David C Fajgenbaum, Craig Tendler, British Journal of Haematology

Abstracts/Posters

• Quantitative Changes in Serum Proteins Including CXCL13 Are Early Indicators of Response to Anti-IL6 Therapy in Idiopathic Multicentric Castleman Disease
  Craig Tendler, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019